176 related articles for article (PubMed ID: 14662972)
21. Clinical and laboratory correlations in patients with cystic fibrosis and Pseudomonas aeruginosa infection: The experience of a regional centre.
Smădeanu R; Moşescu S; Zăpucioiu C; Orăşeanu D
Pneumologia; 2016; 65(4):201-6. PubMed ID: 29542902
[TBL] [Abstract][Full Text] [Related]
22. Molecular identification and genotyping of Pseudomonas aeruginosa isolated from cystic fibrosis and non-cystic fibrosis patients with bronchiectasis.
Eusebio N; Amorim AA; Gamboa F; Araujo R
Pathog Dis; 2015 Mar; 73(2):1-7. PubMed ID: 25722487
[TBL] [Abstract][Full Text] [Related]
23. Turnover of strains and intraclonal variation amongst Pseudomonas aeruginosa isolates from paediatric CF patients.
Hall AJ; Fothergill JL; McNamara PS; Southern KW; Winstanley C
Diagn Microbiol Infect Dis; 2014 Dec; 80(4):324-6. PubMed ID: 25284374
[TBL] [Abstract][Full Text] [Related]
24. Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Tai AS; Sherrard LJ; Kidd TJ; Ramsay KA; Buckley C; Syrmis M; Grimwood K; Bell SC; Whiley DM
BMC Pulm Med; 2017 Nov; 17(1):138. PubMed ID: 29096618
[TBL] [Abstract][Full Text] [Related]
25. Pseudomonas aeruginosa diversity in distinct paediatric patient groups.
Tramper-Stranders GA; van der Ent CK; Wolfs TF; Kimpen JL; Fleer A; Johansen U; Johansen HK; Høiby N
Clin Microbiol Infect; 2008 Oct; 14(10):935-41. PubMed ID: 18752596
[TBL] [Abstract][Full Text] [Related]
26. Acute effects of viral respiratory tract infections on sputum bacterial density during CF pulmonary exacerbations.
Chin M; De Zoysa M; Slinger R; Gaudet E; Vandemheen KL; Chan F; Hyde L; Mah TF; Ferris W; Mallick R; Aaron SD
J Cyst Fibros; 2015 Jul; 14(4):482-9. PubMed ID: 25544473
[TBL] [Abstract][Full Text] [Related]
27. Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis.
Speert DP; Campbell ME
J Hosp Infect; 1987 Jan; 9(1):11-21. PubMed ID: 2880893
[TBL] [Abstract][Full Text] [Related]
28. Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study.
Connett GJ; Pike KC; Legg JP; Cathie K; Dewar A; Foote K; Harris A; Faust SN
Ther Adv Respir Dis; 2015 Dec; 9(6):272-80. PubMed ID: 26341118
[TBL] [Abstract][Full Text] [Related]
29. How and why to monitor Pseudomonas aeruginosa infections in the long term at a cystic fibrosis centre.
Kalferstova L; Vilimovska Dedeckova K; Antuskova M; Melter O; Drevinek P
J Hosp Infect; 2016 Jan; 92(1):54-60. PubMed ID: 26597636
[TBL] [Abstract][Full Text] [Related]
30. Pseudomonas aeruginosa infection and cystic fibrosis.
Kato K; Takayama T
Lancet; 2002 Jan; 359(9302):262. PubMed ID: 11812595
[No Abstract] [Full Text] [Related]
31. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales.
Scott FW; Pitt TL
J Med Microbiol; 2004 Jul; 53(Pt 7):609-615. PubMed ID: 15184530
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis.
Parkins MD; Somayaji R; Waters VJ
Clin Microbiol Rev; 2018 Oct; 31(4):. PubMed ID: 30158299
[TBL] [Abstract][Full Text] [Related]
33. Low serum mannose-binding lectin level is not associated with disease severity in non-cystic fibrosis bronchiectasis.
Macfarlane JG; Jary H; Hester KL; McAlinden P; Wake J; Small T; Walton KE; Spickett G; De Soyza A
Innate Immun; 2012 Dec; 18(6):787-92. PubMed ID: 22382779
[TBL] [Abstract][Full Text] [Related]
34. Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis centre.
Wee BA; Tai AS; Sherrard LJ; Ben Zakour NL; Hanks KR; Kidd TJ; Ramsay KA; Lamont I; Whiley DM; Bell SC; Beatson SA
BMC Genomics; 2018 Aug; 19(1):644. PubMed ID: 30165811
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada.
Speert DP; Campbell ME; Henry DA; Milner R; Taha F; Gravelle A; Davidson AG; Wong LT; Mahenthiralingam E
Am J Respir Crit Care Med; 2002 Oct; 166(7):988-93. PubMed ID: 12359659
[TBL] [Abstract][Full Text] [Related]
36. Of isolates and isolation: Pseudomonas aeruginosa in adults with cystic fibrosis.
Geddes DM
Lancet; 2001 Aug; 358(9281):522-3. PubMed ID: 11520516
[No Abstract] [Full Text] [Related]
37. Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network.
Chalmers JD; Ringshausen FC; Harris B; Elborn JS; Posthumus A; Haworth CS; Pilkington N; Polverino E; Ruddy T; Aliberti S; Goeminne PC; Winstanley C; De Soyza A
Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29326319
[No Abstract] [Full Text] [Related]
38. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
Schiller NL; Millard RL
Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945
[TBL] [Abstract][Full Text] [Related]
39. Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains.
Varga JJ; Barbier M; Mulet X; Bielecki P; Bartell JA; Owings JP; Martinez-Ramos I; Hittle LE; Davis MR; Damron FH; Liechti GW; Puchałka J; dos Santos VA; Ernst RK; Papin JA; Albertí S; Oliver A; Goldberg JB
BMC Genomics; 2015 Oct; 16():883. PubMed ID: 26519161
[TBL] [Abstract][Full Text] [Related]
40. Mixed morphotype susceptibility testing of Pseudomonas aeruginosa from patients with cystic fibrosis.
Dunne WM; Chusid MJ
Diagn Microbiol Infect Dis; 1987 Feb; 6(2):165-70. PubMed ID: 3102157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
